ArticleThe European journal of health economics : HEPAC : health economics in prevention and care2025

Cost-effectiveness of hydroxychloroquine retinopathy screening: the current guideline versus no screening and reduced regimens.

Sara W Quist et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.